Feedback
Mucopolysaccharidosis Type 1, Total HS and NRE (Sensi-Pro) Quantitative, Serum or Plasma
2007599
Ordering Recommendation

Use to monitor heparan sulfate (total disaccharides and nonreducing ends) for  MPS Type 1 patients who are on therapy.

Mnemonic
MPSI QNT S
Methodology
Liquid Chromatography-Tandem Mass Spectrometry
Performed
Mon
Reported
2-3 weeks
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
EDTA (lavender), plain red, or serum separator tube. 
Specimen Preparation
Transfer 500 uL serum or plasma to ARUP Standard Transport Tube and freeze immediately. (Min: 250 uL) 
Storage/Transport Temperature
Frozen. 
Unacceptable Conditions
Plasma collected in Heparin (green) tubes. Ambient or Refrigerated Specimens 
Remarks
 
Stability
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 month (avoid repeated freeze/thaw cycles) 
Reference Interval
By Report
Interpretive Data
Refer to Report

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Components
Component Test Code*Component Chart NameLOINC
2007494MPSI - Heparan Sulfate NRE, Serum/Plasma
2007495MPSI - Heparan Sulfate Total, Ser/Plas
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Heparan Sulfate total and NRE, Serum/Plasma
  • HS non reducing end assay
  • MPS I
  • MPS Type 1